Event Dime

RapidMeta Cardiology: A Browser-Based Living Meta-Analysis Platform Validated Against Finerenone Phase III Trial Data [version 1; peer review: awaiting peer review]

Arts & Culture
When:
June 1, 2026 ยท 3:48 AM
Source:
F1000Research

Background Living meta-analyses are currently hampered by fragmented software, server dependencies, and limited data provenance. We developed and validated RapidMeta Cardiology, a standalone browser-based meta-analysis platform, using Phase III finerenone trial data as a proof-of-concept benchmark. Methods The application implements DerSimonian-Laird (DL) and REML random-effects meta-analysis for odds ratios (OR), risk ratios (RR), and hazard ratios (HR). Five outcomes (MACE, all-cause mortality

Why this event appears here

This listing is shown because it is tied to the current city coverage and carries structured metadata that can be indexed and compared with other events.

  • City coverage

    Local event

  • Primary source

    F1000Research

  • Categories

    Arts & Culture